A contract manufacturing pharmaceutical company is a company that provides contract manufacturing services for a variety of pharmaceutical companies. These companies include Bayer Ingelheim, Hospira, Raphes Global, and One2One. Depending on your needs, you may also use a company that specializes in producing APIs and biologics.
Hospira is a contract manufacturing pharmaceutical company
Hospira is one of the most recognized and trusted contract manufacturers for injectable drugs. Its recent expansion in McPherson, Kansas, USA, allows it to create a wide range of injectable drugs and delivery systems. It has extensive experience manufacturing injectable drugs and delivery systems with CGMP compliance. In addition, the McPherson team specializes in filling parenteral biologic products.
In addition to injectable medications, Hospira also provides a complete range of contract manufacturing services to pharmaceutical companies. The company has more than 70 years of experience developing parenteral agents and 20 years of experience in contract manufacturing. The company has invested in its facilities, establishing five One2One manufacturing facilities in the United States and one in Italy.
Hospira manufactures Products in a variety of batches, including engineering, clinical, and registration batches. The company also produces Development Supplies, which include materials for research and development but are not commercially available.
Raphes Global is a contract manufacturing pharmaceutical company
Raphes Global is a contract manufacturing company that provides pharmaceuticals with quality production at an affordable price. The company offers a wide range of services, including the manufacture of generic and brand-name pharmaceuticals. It also has cGMP-certified production facilities. The company focuses on providing customized solutions and offers a full range of testing capabilities, including stability and efficacy studies.
The contract manufacturing pharmaceutical industry is seeing continued growth due to a variety of factors. These factors include the fracturing of the blockbuster business model, the sputtering global economy, and increasing costs for drug development. But at the same time, these factors are also creating opportunities and accelerating the growth of the global contract pharmaceutical manufacturing industry.
The global pharmaceutical contract manufacturing market is predicted to grow at the fastest rate between 2018 and 2021. The Asia-Pacific region is considered the most dynamic emerging market in the world, with a large base of generic drug producers, growing scientific capabilities and a host of new and improved pharmaceutical manufacturing facilities. In the past two to three years, major players have bolstered their capabilities in this region to make it even more competitive.
Bayer Ingelheim is a contract manufacturing pharmaceutical company
Boehringer Ingelheim is a global enterprise with core competencies in the Life Science fields of biopharmaceuticals, animal health, and veterinary medicine. The company’s mission is to develop products and services that enhance the quality of human life. Through innovation, growth, and high earning power, the company aims to create value for its customers and society. It also adheres to the principles of sustainable development, social responsibility, and corporate citizenship.
Boehringer Ingelheim was founded in Nieder-Ingelheim, Germany, in 1885. Initially, the company manufactured textile dyes and pharmaceutical acid salts. It also developed bacteria that produce lactic acid, which was used in the food, dye, and leather industry. The company continued its R&D and introduced new pharmaceutical products in the field of pulmonary disease. Ingelheim’s production was temporarily halted during World War II, but the company reopened the factory with the consent of its allies and continued manufacturing.
Boehringer Ingelheim has extensive experience in biopharmaceutical contract manufacturing, and has brought to market over 20 biopharmaceutical products. The company has a global network of facilities, including plants in Biberach, Vienna, and Fremont, USA. Its contract manufacturing capabilities are scalable, allowing it to meet the needs of pharmaceutical companies of any size.
One 2 One is a contract manufacturing pharmaceutical company
One 2 One is one of the largest contract manufacturing pharmaceutical companies in the United States. It has a large capacity for filling and lyophilizing injectable products. According to PharmSource, the company’s contract products account for five to 10 percent of the company’s revenue and operating profit. The company does not disclose its capacity, but it fills about fifty to seventy million units a year, mainly vials and lyophilized liquids.
Contract manufacturing is a good option for pharmaceutical companies to outsource certain production activities. These activities may include assembly, components, brand building, and research and development. Contract manufacturers are highly knowledgeable about such projects and know how to assess potential risks. They also have the experience to meet the tightest deadlines and produce a high-quality product.
Contract manufacturing allows pharmaceutical companies to focus their resources on other areas of their business. Contract manufacturers specialize in producing one or two products and can lower their overhead costs by outsourcing manufacturing. This allows pharmaceutical companies to focus on their core competencies.